Skip to content
Open access

Prognostic value of twelve systemic inflammatory indices for composite cardiovascular events in chronic coronary syndrome patients with or without diabetes undergoing PCI

Oct 2026 · European Heart Journal · 0 citations

TL;DR

In diabetic patients with CCS, inflammatory indices such as SII, NLR, and PAR are strong predictors of PCI-related complications, including RR and ISR, and may serve as practical tools for risk stratification.

Abstract

Inflammation is widely recognized as a central contributor to the pathogenesis and prognosis of repeat revascularization (RR) and in-stent restenosis (ISR) following percutaneous coronary intervention (PCI). Diabetes mellitus (DM) not only markedly increases the risk of coronary artery disease (CAD) but also accelerates atherosclerosis progression by exacerbating insulin resistance, promoting chronic low-grade inflammation, and impairing endothelial function. Recent evidence indicates that elevated inflammatory indices independently predict adverse cardiovascular outcomes, particularly in patients with DM. This study aimed to evaluate the prognostic value of twelve inflammatory indices for predicting RR and ISR in diabetic patients with chronic coronary syndrome (CCS) undergoing PCI. A total of 2,079 patients were enrolled, including 867 with diabetes mellitus (DM). Patients were categorized into tertiles based on each inflammatory index. The primary endpoint was a composite of PCI-related complications, including repeat revascularization (RR) and in-stent restenosis (ISR). Associations between the twelve inflammatory indices and outcomes were evaluated using multivariable Cox proportional hazards models and restricted cubic spline (RCS) analyses. During a median follow-up of 60 months, 961 patients (46.2%) experienced at least one composite endpoint. In the overall population, LnSII remained an independent predictor of the composite endpoint after adjustment (HR 1.13, 95% CI 1.01–1.28, P=0.037), while other inflammatory indices showed no significant association. Among non-diabetic patients, none of the indices were predictive. In diabetic patients, SII, NLR, and PAR remained significant independent predictors after adjustment (SII: HR 1.25, 95% CI 1.06–1.47, P=0.009; NLR: HR 1.22, 95% CI 1.01–1.47, P=0.040; PAR: HR 1.38, 95% CI 1.04–1.84, P=0.028). Compared with the lowest tertile (T1), patients in the highest tertile (T3) had a 37%, 33%, and 38% higher risk, respectively. Restricted cubic spline analysis revealed a nonlinear association between SII and the composite endpoint in diabetic patients, while NLR and PAR showed linear associations. Kaplan–Meier analysis further confirmed significantly higher event rates in the T3 groups of SII and NLR among diabetic patients (SII P=0.026; NLR P=0.037), with no significant differences observed in the overall population. In diabetic patients with CCS, inflammatory indices such as SII, NLR, and PAR are strong predictors of PCI-related complications, including RR and ISR, and may serve as practical tools for risk stratification.

Read PDF

Similar papers

Open access Oct 2026

Inflammatory and insulin resistance indicators for predicting in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention

The C-Reactive protein-triglyceride glucose index(CTI), a reliable surrogate indicator of inflammatory and insulin resistance, is independently associated with coronary artery disease of various clinical manifestations. This study aimed to investigate the prognostic value of the CTI index in predicting in-stent r...

Jia-Le Wang, Long-Cheng Liu, Pei-Pei Lu et al. · 0 citations
Open access Sep 2026

Cholesterol, HDL, and glucose index and poor prognosis in acute coronary syndrome after PCI: a cohort study

Dysregulated serum lipids and hyperglycemia are established risk factors for adverse outcomes in acute coronary syndrome (ACS) patients after percutaneous coronary intervention (PCI). The Cholesterol, HDL, Glucose (CHG) index is a novel composite metric integrating glycemic and lipid profiles; however, its prognost...

Zai-Qiang Liu, Yu-Xiu Yang, Qiu-Xuan Li et al. · 0 citations
Open access Oct 2026

Nomogram for predicting post-percutaneous coronary intervention restenosis in patients with coronary artery disease and diabetes: a retrospective study

Key predictive factors for post-PCI restenosis in CAD patients with DM through case-control analysis were identified and the nomogram model showed good discrimination on internal bootstrap validation, and may provide a useful exploratory tool to support risk stratification and inform management aimed at reducing the re...

Ping Wang, Hong-Yu Peng, Qian Fan et al. · 0 citations
Open access Sep 2026

Predictive Value of the Triglyceride–Glucose Index for Major Adverse Cardiovascular Events in Patients with Premature Coronary Artery Disease

The admission TyG index did not show a statistically significant relationship with coronary anatomical severity or long-term clinical outcomes in premature CAD, and risk assessment in acute coronary patients should continue to prioritize established clinical, acute inflammatory, and angiographic parameters.

Saadet Bülüç, F. Akın, Oğuzhan Çelik et al. · 0 citations
Open access Nov 2026

Inflammatory and Insulin Resistance Indicator for Predicting Repeat Revascularization and In‐Stent Restenosis in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention

ABSTRACT Objective The C‐reactive protein‐triglyceride glucose index (CTI) has been associated with cardiovascular risk. This study evaluated its prognostic value for repeat revascularization and in‐stent restenosis (ISR) in patients with chronic coronary syndrome (CCS) undergoing percutaneous coronary intervention (PC...

Jia-Le Wang, Long-Cheng Liu, Pei-Pei Lu et al. · 0 citations
Review Open access Oct 2026

Impact of diabetes mellitus on clinical outcomes after percutaneous coronary intervention for chronic total occlusions in the drug-eluting stent era: a systematic review and meta-analysis

DM is identified as an important prognostic modifier after CTO-PCI in the contemporary DES era and the need for secondary prevention strategies in this high-risk population is highlighted.

L. Dasilva, E. D. da Silva, R. Suruagy-Motta et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.